Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Cardiac risk factors and prevention
Email alerts
Cardiac risk factors and prevention
Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
David Charles
Hutchings
,
Simon George
Anderson
,
Andrew W
Trafford
Heart
Nov 2017,
103
(21)
1745;
DOI:
10.1136/heartjnl-2017-311788
Sex differences in survival after myocardial infarction in Sweden, 1987–2010
Johanna
Berg
,
Lena
Björck
,
Susanne
Nielsen
,
Georgios
Lappas
,
Annika
Rosengren
Heart
Oct 2017,
103
(20)
1625-1630;
DOI:
10.1136/heartjnl-2016-310281
Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
Ahmed
AlBadri
,
Janet
Wei
,
Puja K
Mehta
,
Rashmee
Shah
,
Romana
Herscovici
,
Martha
Gulati
,
Chrisandra
Shufelt
,
Noel
Bairey Merz
Heart
Oct 2017,
103
(20)
1567-1568;
DOI:
10.1136/heartjnl-2017-311921
Physical activity evaluation in children with congenital heart disease
Christine
Voss
,
Kevin C
Harris
Heart
Sep 2017,
103
(18)
1408-1412;
DOI:
10.1136/heartjnl-2017-311340
Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?
Yutaka
Furukawa
Heart
Sep 2017,
103
(17)
1310-1312;
DOI:
10.1136/heartjnl-2017-311331
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
Louis
Potier
,
Ronan
Roussel
,
Yedid
Elbez
,
Michel
Marre
,
Uwe
Zeymer
,
Christopher M
Reid
,
Magnus
Ohman
,
Kim A
Eagle
,
Deepak L
Bhatt
,
Philippe Gabriel
Steg
Heart
Sep 2017,
103
(17)
1339-1346;
DOI:
10.1136/heartjnl-2016-310705
Chocolate and prevention of atrial fibrillation: what is bad for the pancreas might be good for the atria?
Sean D
Pokorney
,
Jonathan P
Piccini
Heart
Aug 2017,
103
(15)
1141-1142;
DOI:
10.1136/heartjnl-2016-311026
Predicting the future of cardiovascular risk prediction
Amitava
Banerjee
Heart
Jun 2017,
103
(12)
891-892;
DOI:
10.1136/heartjnl-2016-311141
Text messaging for prevention and treatment of cardiovascular disease: time to move on
Milena Soriano
Marcolino
,
João Antonio de Queiroz
Oliveira
,
Antonio Luiz
Ribeiro
Heart
Jun 2017,
103
(12)
893-894;
DOI:
10.1136/heartjnl-2016-311135
Integrated programmes for cardiovascular disease risk reduction: the need for new models of care
Sandra N
Ofori
Heart
Jun 2017,
103
(11)
805-806;
DOI:
10.1136/heartjnl-2016-311084
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »
CLINICAL
Cardiovascular medicine
Arrhythmias
Bradyarrhythmias and heart block
(268)
Tachyarrhythmias
(225)
Cardiomyopathy
Dilated cardiomyopathy
(325)
Hypertrophic cardiomyopathy
(388)
Restrictive cardiomyopathy
(36)
Congenital heart disease
(879)
Drugs: cardiovascular system
(10086)
Echocardiography
(2385)
Heart failure
(620)
Hypertension
(3363)
Interventional cardiology
(3322)
Ischaemic heart disease
Acute coronary syndromes
(3126)
Percutaneous intervention
(1096)
Stable coronary heart disease
(210)
Pacing and electrophysiology
(295)
Valvar diseases
Aortic valve disease
(513)
Mitral valve disease
(275)
Right sided valvular heart disease
(159)
Venous thromboembolism
(572)
Diagnostics
Clinical diagnostic tests
(5281)
Endocrinology
Diabetes
(920)
Metabolic disorders
(1160)
Sport and exercise medicine
(6)
NON-CLINICAL
Communication
Epidemiology
(4620)
Health policy
(275)
Healthcare improvement and patient safety
Hospital ratings
Surgical mortality
Occupational and environmental medicine
Disease and health outcomes
Cardiovascular
Smoking and tobacco
Environmental tobacco smoke
Health effects of tobacco use
(31)
Smoking cessation
(70)
Tobacco use
(719)
Special collections
Cardiology in Focus
(55)
Cochrane Corner
(36)
Guidelines, Recommendations and Consensus Statements
(2)
Image challenges
(245)
Press releases
(114)
Review articles
(494)
Education in Heart
(796)
Education in Heart
Acute cardiovascular care
(14)
Acute coronary syndromes
(79)
Arrhythmias
(26)
Atrial fibrillation and flutter
(7)
Cardiovascular prevention
(17)
Chronic ischaemic heart disease
(11)
Clinical pharmacology
(9)
Congenital heart disease in adult patients
(233)
Diseases of the aorta and trauma to the aorta and heart
(2)
Genetics
(2)
Heart failure
(53)
History taking and clinical examination
(8)
Infective endocarditis
(2)
Invasive imaging: cardiac catheterization and angiography
(12)
Myocardial disease
(25)
Non-invasive imaging
(43)
Oncology and the heart
(1)
Pericardial disease
(3)
Peripheral arterial disease
Physical activity and sport in primary and secondary prevention
Pregnancy & heart disease
(4)
Pulmonary arterial hypertension
(6)
Sudden cardiac death & resuscitation
(4)
Syncope
The cardiac consult
(2)
The electrocardiogram
Thromboembolic venous disease
(2)
Valvular heart disease
(113)
Editor's choice
(315)
Open access
(859)